214
Views
8
CrossRef citations to date
0
Altmetric
Research Articles

Long-term prescribing of nitrofurantoin for urinary tract infections (UTI) in veterans with spinal cord injury (SCI)

, , , , , & show all

References

  • NINDS. Spinal Cord Injury: Hope Through Research. July 2013. http://www.ninds.nih.gov/disorders/sci/detail_sci.htm?css=print. Accessed October 12, 2014.
  • Whiteneck GG, Charlifue SW, Frankel HL, Fraser MH, Gardner BP, Gerhart KA, et al. Mortality, morbidity, and psychosocial outcomes of persons SCI more than 20 years ago. Paraplegia 1992;30(9):617-30.
  • Vickrey BG, Shekelle P, Morton S, Clark K, Pathak M, Kamberg C. Prevention and management of UTIs in paralyzed persons. Evid Rep Technol Assess (Summ) 1999;(6):1-3.
  • Evans CT, Rogers TJ, Chin AM, Johnson S, Smith B, Weaver FM, et al. Antibiotic prescribing trends in the emergency department for Veterans with SCI/D 2002-2007. J Spinal Cord Med 2013;36(5):492-8. doi: 10.1179/2045772312Y.0000000076
  • Mylotte JM, Graham R, Kahler L, Young L, Goodnough S. Epidemiology of nosocomial infection and resistant organisms in patients admitted for the first time to an acute rehabilitation unit. Clin Infect Dis 2000;30(3):425-32. doi: 10.1086/313708
  • The prevention and management of urinary tract infections among people with spinal cord injuries: National Institute on Disability and Rehabilitation Research Consensus Statement: January 27-29. 1992. J Am Paraplegia Soc 1992;15(3):194-204. doi: 10.1080/01952307.1992.11735873
  • Esclarin De Ruz A, Garcia Leoni E, Herruzo Cabrera R. Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J Urol 2000;164(4):1285–9.
  • Noreau L, Proulx P, Gagnon L, Drolet M, Laramée MT. Secondary impairments after SCI: a population-based study. Am J Phys Med Rehabil 2000;79(6):526-35. doi: 10.1097/00002060-200011000-00009
  • Evans CT, Levela SL, Weaver FM, Priebe M, Sandford P, Niemiec P, et al. Epidemiology of hospital-acquired infections in veterans with SCI/D. Infect Control Hosp Epi 2008;29(3):234-42. doi: 10.1086/527509
  • Charlifue SW, Weitzenkamp DA, Whiteneck GG. Longitudinal outcomes in SCI: aging, secondary conditions, and well-being. Arch Phys Med Rehabil.1999;80(11):1429-34. doi: 10.1016/S0003-9993(99)90254-X
  • Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America.
  • Phillips CD, Adepoju O, Stone N, Moudouni DK, Nwaiwu O, Zhao H, et al. Asymptomatic bacteriuria, antibiotic use, and suspected urinary tract infections in four nursing homes. BMC Geriatr 2012;12:73. doi: 10.1186/1471-2318-12-73
  • Morton SC, Shekelle PG, Adams JL, Bennett C, Dobkin BH, Montgomerie J, et al. Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil 2002;83(1):129-38. doi: 10.1053/apmr.2002.26605
  • Niël-Weise BS, van den Broek PJ, da Silva EM, Silva LA. Urinary catheter policies for long-term bladder drainage. Cochrane Database Syst Rev 2012;(8):CD004201.
  • Macrobid®[package insert]. Cincinnati, OH: Procter and Gamble Pharmaceuticals, Inc.; Oct 2007.
  • Fitzpatrick MA, Suda KJ, Safdar N, Burns SP, Jones MM, Poggensee, et al. Changes in bacterial epidemiology and antibiotic resistance among veterans with spinal cord injury/disorder over the past 9 years. J Spinal Cord Med. 2017;41:199-207. doi: 10.1080/10790268.2017.1281373
  • Suda KJ, Patel UC, Sabzwari R, Cao L, Ramanathan S, Hill JN, Evans CT. Bacterial susceptibility patterns in patients with spinal cord injury and disorder (SCI/D): an opportunity for customized stewardship tools. Spinal Cord. 2016;54:1001-9. doi: 10.1038/sc.2016.38
  • Sanchez GV, Master RN, Karlowsky JA, Bordon JM. In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010. Antimicrob Agents Chemother 2012;56(4):2181-3.
  • Anderson RU. Prophylaxis of bacteriuria during intermittent catheterization of the acute neurogenic bladder. J Urol 1980;123(3):364-6. doi: 10.1016/S0022-5347(17)55938-8
  • Kashanian J, Hakimian P, Blute M Jr., Wong J, Khanna H, Wise G, et al. Nitrofurantoin: the return of an old friend in the wake of growing resistance. BJU Int 2008;102(11):1634-7. doi: 10.1111/j.1464-410X.2008.07809.x
  • Brumfitt W, Hamilton-Miller JM. Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years’ experience. J Antimicrob Chemother 1998;42(3):363-71. doi: 10.1093/jac/42.3.363
  • Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother 2002;46(8):2540-5. doi: 10.1128/AAC.46.8.2540-2545.2002
  • Biering-Sørensen F, Høiby N, Nordenbo A, Ravnborg M, Bruun B, Rahm V. Ciprofloxacin as prophylaxis for urinary tract infection: prospective, randomized, cross-over, placebo controlled study in patients with spinal cord lesion. J Urol 1994;151(1):105-8. doi: 10.1016/S0022-5347(17)34882-6
  • Kuhlemeier KV, Stover SL, Lloyd LK. Prophylactic antibacterial therapy for preventing urinary tract infections in spinal cord injury patients. J Urol 1985;134(3):514-6. doi: 10.1016/S0022-5347(17)47268-5
  • Lindan, R, Joiner, E. A prospective study of the efficacy of low dose nitrofurantoin in preventing urinary tract infections in spinal cord injury patients, with comments on the role of pseudomonas. Paraplegia 1984;22(2):61-5.
  • Salomon J, Denys P, Merle C, Chartier-Kastler E, Perronne C, Gaillard JL, et al. Prevention of urinary tract infection in spinal cord-injured patients: safety and efficacy of a weekly oral cyclic antibiotic (WOCA) programme with a 2 year follow-up--an observational prospective study. J Antimicrob Chemother 2006;57(4):784-8. doi: 10.1093/jac/dkl010
  • Spinal Cord Injuries and Disorders System of Care. U.S. Department of Veterans Affairs. 10 Jun. 2016. http://www.sci.va.gov/. Accessed July 23, 2016.
  • Cardenas DD, Hooton TM. Urinary Tract Infection in Persons with Spinal Cord Injury. Arch Phys Med Rehabil 1995;76(3):272-80. doi: 10.1016/S0003-9993(95)80615-6
  • Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-third Informational Supplement M100-S23. CLSI: Wayne, PA, USA. 2013.
  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-83. doi: 10.1016/0021-9681(87)90171-8
  • Conklin JD. The pharmacokinetics of nitrofurantoin and its related bioavailability. Antibiot Chemother (1971) 1978;25:233-52. doi: 10.1159/000401065
  • Trautner BW, Grigoryan L, Petersen NJ, Hysong S, Cadena J, Patterson JE, et al. Effectiveness of an Antimicrobial Stewardship Approach for Urinary Catheter-Associated Asymptomatic Bacteriuria. JAMA Intern Med 2015;175(7):1120-7. doi: 10.1001/jamainternmed.2015.1878
  • Shamna M, Dilip C, Ajmal M, Linu Mohan P, Shinu C, Jafer CP, et al. A prospective study on Adverse Drug Reactions of antibiotics in a tertiary care hospital. Saudi Pharm J 2014;22(4):303-8. doi: 10.1016/j.jsps.2013.06.004

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.